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AMINOSTILBAMIDJNE—A FUNGISTATIC AGENT
IN VITRO SENSITIVITY STUDIES, TISSUE FLUORESCENCE—DISTRIBUTION, AND
THERAPEUTIC TRIALS IN COCCIDIOIDOMYCOSIS*
D. S. KUSHNER, M.D., I. SNAPPER, M.D., M. SENDERI, M.D. AND
S. McMILLEN, M.S.
Recent demonstration of the therapeutic efficacy of stilbamidine and 2-hy-
droxystilbamidine in blastomycosis (1—9) has stimulated investigation of other
diamidine derivatives as fungistatic agents. Hydroxystilbamidine has been
shown to have some suppressive influence on the course of coccidioidomycosis
(10—12). Substitution of an amino for the hydroxy group results in a highly
soluble orange crystalline compound, designated as aminostilbamidine. This
newest stilbamidine derivative effectively inhibits the in vitro growth of C.
immitis. The present study was directed toward establishing the in vitro spectrum
of sensitivity of the important "systemic" fungi, evaluation of therapeutic
efficacy in five patients with coccidioidomycosis, and observations of the human
tissue concentration and distribution of aminostilbamidine.
In Vitro Sensitivity Studies
Inhibition of Blastomyces dermatitidis and Coccidioides immitis occurred at
concentrations of 25 mcg/ml of aminostilbamidine (Table I), a level similar to
that required for complete inhibition of blastomyces by other stilbamidine
compounds (13). No effective inhibition of cryptococcus, nocardia or candida
was observed.
Toxicity Studies (14)
Aminostilbamidine injected intravenously into mice has approximately the
same acute toxicity as hydroxystilbamidine. Its chronic toxicity in guinea pigs
is also roughly similar to that of hydroxystilbamidine. Minimal fatty liver
degeneration occurred at the dosage level of 10 mg/kg.
Therapeutic Trials
Case 1. (Previously reported (12).) A 28 year Did Air FDrce sergeant, previously stationed
in Texas and Wyoming, was found on routine examination in December, 1951 to have a
solitary pulmonary nodule in the right upper lobe. A wedge resection was performed in
January, 1952 and a histologic diagnosis of coccidioidal granuloma was made. Postopera-
tive empyema required repeated drainage and excision of sinus tracts containing Cocci-
dioides immilis. Meningitis developed in July, 1952 with symptoms of headache, photo-
phobia, findings of nuchal rigidity, papilledema, and fever. Cerebrospinal fluid showed
increased pressure (160 mm.), 2000 leukocytes, protein 147 mg., sugar 52 mg., chloride 690
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TABLE I
Comparison of in vitro sensitivity to Aminostilbamidine of C. immitis with
that of other fungi
Organism No. of StrainsStudied
No. of Strains
Inhibited
Drug Concentration
mcg./mI.
Blastomyces dermatitidis* 12 1 1
9
2
5
10
Nocardia asteroides 3 0 100
Cryptococcus neoformans 4 1 250
3 500
Candida albicans 2 0 250
Coccidioides immitist 2 2 25
* Yeast phase.
t Tissue phase. Spherule-rich pus, aspirated from subcutaneous abscesses, was used as
inoculum.
mg./100 cc., and spherules of C. immitis. Right empyema persisted, and clubbing and spleno-
megaly were noted. Serum globulin was 4.23 gm./100 cc. and ESR was 26 mm./hr.
Considerable clinical improvement occurred in the months following treatment with
hydroxystilbamidine, in total dosage of 23 gm. However, in June, 1954, while asymptomatic
and working as a truck driver, evidence of residual low grade infection persisted. Spinal
fluid contained 160 cells/eu. mm., glucose was lowered to 36 mg./100 cc., and protein was
elevated to 200 mg./100 cc., although spinal fluid now remained sterile. Serum and spinal
fluid complement fixation titers remained unchanged (1:64 and 1:16 respectively).
From June 23 to July 9 a course of treatment with aminostilbamidine was given. 1)aily
injections of 150 mg were given in 200 cc. of 5 per cent dextrose in distilled water to a total
of 1850 mg. There were no side effects and the patient was discharged asymptomatic.
For one and a half years he remained well, daily driving a milk truck a distance of 120
miles. He was asymptomatie until November, 1955 when severe headache, slight diplopia
and vomiting developed. His general condition was excellent. Findings included nuehal
rigidity and bilateral papilledema. Examination of spinal fluid revealed pressure of 305
mm, 460 cells/eu. mm., glucose 18 mg. and protein 187 mg./lOO cc. All cultures were nega-
tive. After two spinal taps the meningeal signs disappeared and aminostilbamidine therapy
was resumed. The drug was discontinued, after a total dosage of 5.25 gm. had been given,
because of the appearance of tremor of the extremities. Roentgenogram of the chest was
normal. The number of cells of the spinal fluid decreased to about 200/cu. mm. The de-
creased glucose and increased albumin content remained stationary. Titer of serum com-
plement fixation test was unchanged (1:64). Hepatic and renal function remained normal.
Although the papilledema had receded and neurologic examination was negative, the
headaches recurred frequently. The headache was always relieved after a spinal tap but
within a week the pain recurred to such a degree that repeat spinal tap was necessary.
After a few weeks urination became difficult and a cord bladder with complete loss of con-
trol of bladder function developed. It was, therefore, decided to try to decrease the pres-
sure of the spinal fluid by making a communication between the spinal canal and the mar-
row of the fifth lumbar vertebra.
After this operation had been performed on February 28, 1956, the bladder control re-
turned. Rather severe pains in the left thigh appeared, possibly connected with pressure
of the catheter introduced in the spinal canal on one of the lumbar roots.
Case No. 0 (Previously reported (12).) A 22 year old Negro farm laborer became ill in
August, 1951, while working as a farm laborer in the San Joaquin valley, with complaints
of fever, cough, weight loss, chest pain, purulent sputum, and weakness. During the en-
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suing months, recurrent tender subcutaneous masses were incised or drained spontaneously,
forming persistent draining sinuses on the chest wall, forearms, and in the presternal area.
Tn April, 1952, roentgenograms showed right upper lobe pneumonitis, and periostitis and
destruction of right fifth and tenth ribs. Coccidioides immitis was recovered both from
sputum and from drainage of subcutaneous sinuses. Serum complement fixation and pre-
cipitin tests were positive (1:32 and 1:40 respectively).
Tn October 1952 a course of stilbamidinc therapy totalling 1.65 gm. was given, with some
symptomatic improvement. Tn March, 1953 the patient was admitted to Cook County
Hospital with persistent complaints. He was emaciated and febrile, with multiple chronic
draining skin ulcerations and sinuses, right supraclavicular abscess, and localized rib ten-
derness. Blood globulin level ranged from 4.0 to 5.5 gm./100 ml. Roentgenograms again
showed pneumonitis and rib destruction. Sputum and sinus drainage contained C. iinm.itis.
Coccidioidin skin test was positive (1:100). Hepatic and renal function were normal.
Treatment with 2-hydroxystilbamidine totalling 20 gm. from April 1, 1953 to July 24,
1953 resulted in diminution in size and in drainage from skin ulcers and sinuses, but general
condition remained unchanged. Subsequently the patient developed a purulent arthritis
involving both ankles. A six week course of isonicotinic acid hydrazide (300 mg./day)
effected no change. Recurrent crops of new abscesses appeared on the chest wall, upper
extremities and fcmoral areas. Tn January, 1954 a left psoas abscess appeared, manifested
by flank pain, psoas spasm, and an enlarging flank mass.
Treatment with aminostilbamidine was instituted January 9, 1953; the drug was given
in dosage of 150 mg./day, dissolved in 200 cc. of 5 per cent dextrose in distilled water and
administered by slow direct intravenous injection. The injections were usually accom-
panied by mild generalized pruritis which was controlled by reducing the rate of injection.
After a total of 3.35 gm. the daily dose was increased to 250 mg.; at a total dose of 4.25 gm.
nausea appeared and persisted; at 6.6 gm. (2/18/54) therapy was temporarily discontinued
because of persistent vomiting and weight loss. Treatment with 150 mg./day was resumed
on 3/6/54. Yellow discoloration of the skin was noted after a total dose of 7 gm. had been
given. Hepatic and renal function remained normal. The left flank abscess gradually sub-
sided. However, low grade fever ranging to 100° persisted and the patient's general condi-
tion progressively deteriorated. Aminostilbamidine administration was discontinued 4/3/54
after a total dose of 10 gm. had been given. Serum complement fixation tests showed a
progressive rise in titer to 1:512. Sacral decubitus ulcers and oral moniliasis developed. On
4/9/54 the patient expired after a total duration of illness of three years.
At necropsy extensive osteomyclitis of the lumbar spine was found which had led to
bilateral psoas abscesses from which C. irnrniti.s was easily cultured. Coccidioidal granu-
lomas were found histologically in the spleen, lungs, lymph nodes, and bone. Tn addition,
pure cultures of Candida albicans were obtained from non-caseating granulomas of lung
and lymph node. Apparently a terminal moniliasis complicated the progressive coccidioido-
mycosis.
Comment
The disseminated coccodioidal infection pursued a relentless, progressive course un-
affected by all therapy including aminostilbamidinc. The patient's general condition was
grave prior to therapy and the drug was poorly tolerated.
Case No. 3•* A 26 year old white male welder became ill following a visit to El Paso,
Texas in January 1953 with onset of complaints in March 1953 of chest pain, cough, expecto-
ration of purulent and blood streaked sputum, weakness, headache, vomiting and fever.
Initial examination revealed nuchal rigidity, increased ccrchrospinal fluid pressure, pleo-
* Clinical and pathologic observations of this patient were permitted through the co-
operation of Dr. Craig Borden, Chief of Medicine, and 1)r. Henry Telo, Pathologist, Vet-
erans Administration Research Hospital, Chicago, Ill.
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cytosis (1100 cells), increased protein (125 mg./100 ml.) and decreased sugar (12.5 mg./
100 ml.). Chest roentgenogram showed thin-walled multilocular cavities in the right upper
lobe. Coccidioidin skin test was negative. Culture of spinal fluid was sterile but C. immilis
was grown from sputum.
On transfer to the V.A. Research Hospital (Chicago, Ill.) the patient's only complaints
were headache, nausea, and occasional vomiting. Pertinent physical signs included slight
nuchal rigidity, positive Brudzinski sign, bilateral papilledema, and palpable spleen tip.
Sedimentation rate was 16 mm./hr.; hemogram and urinalysis were normal. Serum albumin
was 4.0 gm., globulin 4.0 gm. per 100 ml. Cephalin and thymol flocculation tests were nor-
mal. Phenosulfonphthalein excretion was 48 per cent in 15 minutes. Examination of spinal
fluid revealed pressure of 280 mm. of water, 428 cells (95 per cent lymphocytes), protein
240 mg., sugar 38 mg./100 ml. and chloride 100 mEq/L, but no organisms were seen or grown.
Sputum culture again showed C. immitis and coccidioidin skin test remained negative.
Serologic tests (performed by I)r. Charles E. Smith) showed (on 6/29/54) blood comple-
ment fixation titer of 1:32, and in spinal fluid complement fixation 1:256, precipitin 1:40,
confirming disseminated coccidioidal infection with meningitis.
Treatment with aminostilbamidine was instituted on 7/2/54. The drug was diluted in
200 cc of normal saline and given by rapid intravenous drip. Initially 150 mg. was given
daily for three days, then 200 mg./day was given to a total dosage of 10 grams, completed
9/21/54. The drug was well tolerated without side effects.
Two to three weeks after institution of therapy the patient became completely asymp-
tomatic. A beginning yellowish discoloration of the skin was noted. The results of hepatic
and renal function tests remained normal. Serum globulin fell to 2.5 gm/lOU ml. Low grade
fever ranging to 1000 persisted during July and August; during September and October
temperature remained normal. Serial examinations of spinal fluid showed return of pressure
to normal, some decrease of pleocytosis (to 116 cells), rise of sugar (to 60 mg./100 ml.),
but progressive rise of protein (280 mg., 840 mg., 1800 mg./100 ml.). Serum complement
fixation titers persisted unchanged.
However, the patient remained free of symptoms only for several weeks. He then began
to complain of midscapular pain and numbness and tingling of the lower trunk and both
lower extremities. In September, 1954 weakness of both legs appeared and rapidly pro-
gressed. He was readmitted with paresis and hyper-refiexia of both lower extremities, bi-
lateral Babinski signs and tenderness over the third dorsal spine. Papilledema had per-
sisted. A sensory level was found at the fourth dorsal segment. Lumbar puncture (10/13/54)
showed xanthochromic fluid, protein 1800 mg., sugar 29 mg/lOU ml., and 86 cells. Spine
films were normal. Myelogram showed a block at the level of D-10. Thoracic laminectomy
on 10/14 revealed an extensive thickened arachnoid granulation tissue surrounding the
spinal cord; biopsy revealed C. immi/is in the granulation tissue. The patient expired on
10/16/54.
Necropsy diagnoses included: (1) Chronic and acute purulent meningitis due to C. im-
mi/is; bronchopneumonia, right upper and lower lobes.
Comment
Coincident with administration of aminostilbamidine the patient became free of symp-
toms, temperature became normal, serum globulin returned to normal, and an apparent
improvement in the spinal fluid findings was manifested by decrease of pressure and cell
count and rise of glucose level. However, as the meningitis subsided, a localized granuloma
caused partial cord transection and typical cerebrospinal fluid findings of spinal block.
Although laminectomy was imperative, it undoubtedly contributed to renewed generaliza-
tion of meningitis. Although it is possible that the meningitis was suppressed by amino-
stilbamidine treatment, sufficient activity remained for the formation of localized granu
lation tissue at the site of the block.
Case No. 4: A 21 year old white male became ill in August, 1950 with the first of several
recurrent episodes of bilateral spontaneous pneumothorax. Hospitalization from August,
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1951 to January, 1952 failed to define the etiology of a right upper lobe cavity measuring
1.5 x 1.0 cm. Following pneumoperitoneum in May, 1952 the cavity decreased in size and
surrounding reaction lessened. Bronchial and gastric cultures were negative for acid fast.
bacilli. Skin tests showed Mantoux to be positive (PPI) 1) and histoplasmin and cocci-
FIG. 1. Bile duct and hepatic parenchymal cells (Case 2) after 5 months in unstained
glycerol mount (above) showing intense nuclear and only slight cytoplasmic fluorescence.
The same section following H & E stain (below) permits comparison of individual cellular
fluorescence and staining qualities (210 X).
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dioidin doubtful. Following a fifth pneumothorax, segmental resection of the posterior
segment of the right upper lobe was performed on 10/20/52. The histologic diagnosis of the
resected specimeo was coccidioidomycosis which was confirmed by cnlture. Coccidioidin
skin test was now positive and complement fixation titer was 1:80 (blastomyces 1:5). Post-
operatively bronchopleural fistula and empyema developed, requiring a second decortica-
tion procednre on 12/18/52, and on 5/12/53 a thoracoplasty was performed. Pleural cultures
were consistently positive for C. immitis until the bronchopicural fistula closed two months
later. Hepatic and renal functions and blood proteins were normal in July, 1953. From
Fin. 2. A. Moderate fluorescence (above) of unstained normal meninges (Case 2) com-
pared with H & E stain (below) indicating deposition of stilbamidine derivative in appar-
ently normal meninges (50 X). B. Moderate fluorescence (above) of nuclei of neurolemma
in ganglion and nerve fibers (Case 2), compared with H & E stain (below) (50 X).
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(FIG. 2B)
7/20/53 to 10/9/53 a total of 16 gms. of hydroxystilbamidine was given with some anorexia
and nansea. Cultures of gastric washings, which were persistently positive during treat-
ment, were reported negative in October, and only dubiously positive in November. Com-
plement fixation titer was 1:16. The patient was asymptomatic except for failure to gain
weight. ESR was 2-4 mm./hr.
Treatment with aminostilbamidine was begun 12/10/53 with daily intravenous injections
of 225 mg. continued to a total dosage of 2.3 gIn. Side effects were limited to mild nausea
(controlled by 100 mg. of Dramamine® daily) and lemon-yellow discoloration of the skin.
Thereafter seven cultures of gastric washings were negative. The patient gained 4 pounds
and general condition appeared improved.
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FJG. 3. A. Peribronchial lymph node granuloma (Case 2) showing strong fluorescence
(above) of scattered inflammatory cells and of several spherules of C. immitis. Spherules
can be identified in H & E stain (below) (50 X). B. Group of spherules of C. immitis in
lymph node granuloma (Case 2) showiug (above) strong fluorescence of envelope or capsule
and some fluorescence outlining endospores within, compared with H & B stain (below)
(210 X).
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(Fm. SB)
Case No. 5: A 28 year old white male had onset of illness in June 1954 with right chest
pain, hemoptysis, and a large (2 cm.) cavity io the right lower lobe. All skin tests were
positive. Coccidioidcs iminitis was cultured from sputum. Agglutination was positive in
a low titer.
Becanse of bleeding, segmental resection was performed on 10/7/54. Postoperatively a
course of treatment with 2-aminostilbamidine was given for 12 days, in total dosage of
2.75 gm., with no apparent side effects. Sputum diminished in volume and the patient
became asymptomatic and afebrile. On 10/26 sputum culture was still positive and one of
three gastric washings in November and December was positive.
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Studies of Tissue Fluorescence
Distribution of fluorescent drug in tissues was examined in two cases by the
technics previously applied to stilbamidine and hydroxystilbamidine tissue
fluorescence (15). Unstained rehydrated histologic sections from the various
organs were examined microscopically in glycerol mounts, with an ultraviolet
Fio. 4. A. Splenic granuloma (Case 2) showing fluorescence (above) of inflammatory
cells, nuclei of giant cell and spherule of C. immilis,compared in H & E stain (below) (50 X).
B. High power view of same spherule within giant cell with strong fluorescence (above)
compared in TI & E stain (below) (210 X).
I..'.-
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(Fin. 4B)
light source, for the presence of fluorescent material. Photomicrographs were
made of groups of fluorescent cells; following staining (with H & E) the same
cells were photographed in white light for purposes of comparison.
The fluorescence of aminostilbamidine is greenish-yellow in carnoy-fixed
tissues, yellow-orange in formalin-fixed material; it is apparently distinguishable
from the yellow fluorescence of hydroxystilbamidine. In Case 2 the fluorescence
(Figs. t—5) resulted from a mixture of that given by deposits of stilbamidine,
hydroxystilbamidine and ammostilbamidnie which had been given successively.
Both nuclei and cytoplasmic granules present in the various tissues were strongly
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FIG. 5. Spherules of C. immitis (Case 2) showing strong fluorescence (above) of envelope
and of granular material within spherules, identifiable in H & E stain (below) as endo-
spores (210 X).
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Fin. 6. Normal kidney (Case 3) showing strong fluorescence (above) of renal tubular
epithelial cells and weak glomerular fluorescence, compared with H & E stain (below)
(50 X).
:
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FIG. 7. A. Spherule containing giant cell in epidural granuloma, from snrgical (laminec-
tomy) biopsy in Case 3, showing fluorescence (above) of giant cell noclei and of spherule
envelope, compared with H & B stain (below) (50 X). B. Higher magnification of same
(210 x).
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(FIG. 7B)
fluorescent. The granular fluorescence faded after 12 to 48 hours, leaving brilliant
nuclear fluorescence which persisted for at least five months (Fig. 1).
In Case 3 only aminostilbamidine had been administered and the fluorescence
of the tissue was due only to the presence of aminostilbamidine. In both cases,
the most intense fluorescence was observed in nuclei and cytoplasmic granules of
liver, adrenals and kidney (Fig. 6). Less intense but nonetheless strong fluo-
rescence was noted in bronchial epithelium, ductile epithelium generally, leuko-
S
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cytes in inflammatory exudate, and skin. Fluorescence of nerve tissue and
meninges was of lesser intensity. No fluorescence was observed in connective
tissue and in striated muscle.
However, most striking was the fluorescence observed in the spherules of
Coccidioides immitis (Fig. 3, 4, 5 and 7). The envelope of the spherules fluoresced
yellow-green, indicating the specific character of the fluorescence as due to
the aminostilbamidine. Moreover the endospores, when present, also were
fluorescent and thus became visible in the unstained tissue (Fig. 5).
The above findings were identical in each of the two cases examined histo-
logically.
DISCUSSION
The order of in vitro sensitivity of coccidioides to aminostilbamidine ap-
proximates that of both coccidioides and resistant blastomyces to hydroxy-
stilbamidine (13). Since blastomycosis is so amenable to therapy with the
stilbamidines, and some suppression, however unsatisfactory in terms of "cure,"
is achieved in the case of hydroxystilbamidine therapy of coccidioidomycosis, it is
possible that derivative compounds such as aminostilbamidine may have a
higher therapeutic index. The toxicity of aminostilbamidine is low, and in the
dosage administered (maximum 10 gm.) no hepatic or renal toxicity was ob-
served. Side effects coincident with its administration resembled those observed
with the other stilbamidine compounds, namely anorexia, nausea and occa-
sionally vomiting. As is the case with hydroxystilbamidine (12), these side
effects were most pronounced in the patients who were most seriously ill prior
to treatment, and were not observed in the individuals whose general condition
was good prior to therapy.
The tissue distribution of aminostilbamidine is identical with that previously
observed with hydroxystilbamidine (15). Unlike stilbainidine itself, both amino-
and hydroxystilbamidine are contained not only in cellular nuclei but also in
cytoplasmic granules. Aminostilbamidine thus appears to have the same tissue
repository property as hydroxystilbamidine and could, therefore, extend its
fungistatic action over a prolonged period of time following cessation of its
administration.
Nevertheless the clinical response of coccidioidomycosis to aminostilbamidine
therapy was disappointing. Of five patients treated, the two with chronic
coccidioidal meningitis showed no effect specifically attributable to the drug.
The third (Case 2), with progressive disseminated disease, had a relentless
progression to a fatal outcome unaffected by any form of treatment. The two
remaining patients had localized pulmonary disease; in both, symptomatic
improvement followed aminostilbamidine therapy, but in only one did cultures
become sterile. In each of the latter cases the total dose given was small, 2.3 gm.
and 2.75 gm. It is thus possible that in non-meningitic and especially in localized
coccidioidomycosis, aminostilbamidine may exert a suppressive influence on the
course of the infection. However, it is in just such localized coccidioidal lesions
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that evaluation of any form of therapy becomes difficult in view of the notorious
indolence, chronicity and occasional spontaneous remission of such lesions.
SUMMARY
1. Aminostilbamidine was inhibitory to two strains of Coccidioides immitis in
vitro, in concentrations of 25 micrograms/cc. of medium.
2. Five patients with chronic coccidioidomycosis were treated with amino-
stilbamidine in dosage ranging from 2.3 to 10 gm. No curative effect was ob-
served in coceidioidal meningitis. Some suppression of activity possibly oc-
curred in two cases of localized pulmonary disease. No toxicity was observed
other than yellow discoloration of skin and nausea.
3. Tissue fluorescence studies in two cases showed strong fluorescence in
liver, adrenal and kidney cells, in both nuclear and cytoplasmic granules. Lesser
fluorescence was observed in other tissues, indicating the tissue repository
character of the compound. The coccidioides spherules and their endospores were
also strongly fluorescent, indicating incorporation of the compound within the
organism.
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